Agarwal, Arnav;
Agoritsas, Thomas;
Aertgeerts, Bert;
Coyac, Frederic;
Farhoumand, Pauline Darbellay;
Demaine, Andrew;
Fog Heen, Anja;
Foroutan, Farid;
Guyatt, Gordon H;
Jha, Vivekanand;
Li, Sheyu;
Machuve, Edward,;
Nagler, Evi;
Ponte, Belen;
Rayner, Daniel;
Tunnicliffe, David J;
Vandvik, Per Olav;
Zeng, Xiaoxi.
What is the impact of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on survival and on cardiovascular and kidneyoutcomes for adults living with chronic kidney disease (CKD)? Few therapies slow kidney disease progression and improve long term prognosis for adults living with CKD. SGLT-2 inhibitors ha...
Levin, Adeera;
Ahmed, Sofia B;
Carrero, Juan Jesus;
Foster, Bethany;
Francis, Anna;
Hall, Rasheeda K;
Herrington, Will G;
Hill, Guy;
Inker, Lesley A;
Kazancıoğlu, Rümeyza;
Lamb, Edmund;
Lin, Peter;
Madero, Magdalena;
McIntyre, Natasha;
Morrow, Kelly;
Roberts, Glenda;
Sabanayagam, Dharshana;
Schaeffner, Elke;
Shlipak, Michael;
Shroff, Rukshana;
Tangri, Navdeep;
Thanachayanont, Teerawat;
Ulasi, Ifeoma;
Wong, Germaine;
Yang, Chih-Wei;
Zhang, Luxia;
Robinson, Karen A;
Wilson, Lisa;
Wilson, Renee F;
Kasiske, Bertram L;
Cheung, Michael;
Earley, Amy;
Stevens, Paul E.
Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones respecto al
diagnóstico, tratamiento y derivación de las personas con ERC....
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Insuffisance rénale chronique/diagnostic,
Insuffisance rénale chronique/traitement médicamenteux,
Évolution de la maladie,
Triage,
Antagonistes des récepteurs aux angiotensines/usage thérapeutique,
Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique,
Antihypertenseurs/usage thérapeutique,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Hypolipémiants/usage thérapeutique,
Gemfibrozil/usage thérapeutique,
Maladies asymptomatiques,
Association de médicaments,
Approche GRADE
